Published on 17 Jan 2022 on Simply Wall St. via Yahoo Finance
Medtronic plc's (NYSE:MDT) Dismal Stock Performance Reflects Weak Fundamentals
Medtronic (NYSE:MDT) has had a rough three months with its share price down 10%. We decided to study the company's financials to determine if the downtrend will continue as the long-term performance of a company usually dictates market outcomes. In this article, we decided to focus on Medtronic's ROE.
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.
View our latest analysis for Medtronic